{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:53Z","timestamp":1761630533576},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"21-22","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00508-009-1267-7","type":"journal-article","created":{"date-parts":[[2009,12,8]],"date-time":"2009-12-08T12:15:28Z","timestamp":1260274528000},"page":"723-724","source":"Crossref","is-referenced-by-count":6,"title":["Bortezomib induces erythema multiforme-like cutaneous adverse effects: report of two cases"],"prefix":"10.1007","volume":"121","author":[{"given":"Peter Arne","family":"Gerber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"B\u00f6lke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina Alexandra","family":"Buhren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Bruch-Gerharz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Fenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Reifenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried","family":"Budach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Homey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"13-14","key":"1267_CR1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/BF03041029","volume":"115","author":"U J\u00e4ger","year":"2003","unstructured":"J\u00e4ger U (2003) Innovative strategies in lymphoma therapy. Wien Klin Wochenschr 115 (13\u201314): 462\u2013470","journal-title":"Wien Klin Wochenschr"},{"issue":"13-14","key":"1267_CR2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF03041028","volume":"115","author":"H Gisslinger","year":"2003","unstructured":"Gisslinger H, Kees M (2003) Therapy strategies for multiple myeloma: current status. Wien Klin Wochenschr 115 (13\u201314): 451\u2013461","journal-title":"Wien Klin Wochenschr"},{"key":"1267_CR3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000111513","volume":"216","author":"S Sanchez-Politta","year":"2008","unstructured":"Sanchez-Politta S, Favet L, Kerl K, et al (2008) Bortezomib-induced skin eruption. Dermatology 216: 156\u2013158","journal-title":"Dermatology"},{"issue":"4","key":"1267_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.2006.06201.x","volume":"134","author":"J Gerecitano","year":"2006","unstructured":"Gerecitano J, Goy A, Wright J, et al (2006) Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response? Br J Haematol 134 (4): 391\u2013398","journal-title":"Br J Haematol"},{"key":"1267_CR5","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1182\/blood-2002-08-2543","volume":"101","author":"T Hideshima","year":"2003","unstructured":"Hideshima T, Mitsiades C, Akiyama M, et al (2003) Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341. Blood 101: 1530\u20131534","journal-title":"Blood"},{"key":"1267_CR6","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1182\/blood-2006-08-036947","volume":"110","author":"PG Richardson","year":"2007","unstructured":"Richardson PG, Sonneveld P, Schuster M, et al (2007) Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial. Blood 110: 3557\u20133560","journal-title":"Blood"},{"key":"1267_CR7","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2133.2007.08073.x","volume":"157","author":"X Garcia-Navarro","year":"2007","unstructured":"Garcia-Navarro X, Puig L, Fernandez-Figueras MT, et al (2007) Bortezomib-associated cutaneous vasculitis. Br J Dermatol 157: 799\u2013801","journal-title":"Br J Dermatol"},{"issue":"3","key":"1267_CR8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.0902-4441.2005.t01-1-EJH2437.x","volume":"76","author":"CK Min","year":"2006","unstructured":"Min CK, Lee S, Kim YJ, et al (2006) Cutaneous leucoclastic vasculitis (LV) following bortezomib therapy in a myeloma patient; association with pro-inflammatory cytokines. Eur J Haematol 76 (3): 265\u2013268","journal-title":"Eur J Haematol"},{"key":"1267_CR9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1523-1747.1999.00754.x","volume":"113","author":"H Kokuba","year":"1999","unstructured":"Kokuba H, Aurelian L, Burnett J (1999) Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions. J Invest Dermatol 113: 808\u2013815","journal-title":"J Invest Dermatol"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-009-1267-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-009-1267-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-009-1267-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:53:19Z","timestamp":1559080399000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-009-1267-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":9,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["1267"],"URL":"https:\/\/doi.org\/10.1007\/s00508-009-1267-7","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}